ES511238A0 - "un procedimiento para preparar una beta-lactama". - Google Patents

"un procedimiento para preparar una beta-lactama".

Info

Publication number
ES511238A0
ES511238A0 ES511238A ES511238A ES511238A0 ES 511238 A0 ES511238 A0 ES 511238A0 ES 511238 A ES511238 A ES 511238A ES 511238 A ES511238 A ES 511238A ES 511238 A0 ES511238 A0 ES 511238A0
Authority
ES
Spain
Prior art keywords
alkyl
phenyl
substituted phenyl
substituted
phenylalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES511238A
Other languages
English (en)
Spanish (es)
Other versions
ES8307741A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of ES8307741A1 publication Critical patent/ES8307741A1/es
Publication of ES511238A0 publication Critical patent/ES511238A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES511238A 1981-04-09 1982-04-07 "un procedimiento para preparar una beta-lactama". Granted ES511238A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25267281A 1981-04-09 1981-04-09

Publications (2)

Publication Number Publication Date
ES8307741A1 ES8307741A1 (es) 1983-07-01
ES511238A0 true ES511238A0 (es) 1983-07-01

Family

ID=22957021

Family Applications (3)

Application Number Title Priority Date Filing Date
ES511238A Granted ES511238A0 (es) 1981-04-09 1982-04-07 "un procedimiento para preparar una beta-lactama".
ES521479A Granted ES521479A0 (es) 1981-04-09 1983-04-15 Un procedimiento para preparar una beta-lactama.
ES521480A Expired ES8405369A1 (es) 1981-04-09 1983-04-15 Un procedimiento para preparar una beta-lactama.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES521479A Granted ES521479A0 (es) 1981-04-09 1983-04-15 Un procedimiento para preparar una beta-lactama.
ES521480A Expired ES8405369A1 (es) 1981-04-09 1983-04-15 Un procedimiento para preparar una beta-lactama.

Country Status (16)

Country Link
EP (1) EP0062876B1 (en, 2012)
JP (1) JPS57179156A (en, 2012)
AT (1) ATE22439T1 (en, 2012)
AU (1) AU561650B2 (en, 2012)
CA (1) CA1246572A (en, 2012)
DE (1) DE3273405D1 (en, 2012)
DK (1) DK162582A (en, 2012)
ES (3) ES511238A0 (en, 2012)
GR (1) GR76486B (en, 2012)
HU (1) HU187568B (en, 2012)
IE (1) IE52938B1 (en, 2012)
IL (1) IL65407A0 (en, 2012)
NZ (1) NZ199981A (en, 2012)
PH (1) PH23122A (en, 2012)
PT (1) PT74730B (en, 2012)
ZA (1) ZA821768B (en, 2012)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1272726C (en) * 1982-01-04 1990-08-14 2-oxo-1-(aminocarbonylaminosulfonyl- aminocarbonyl)azetidines
US4548747A (en) * 1983-05-02 1985-10-22 E. R. Squibb & Sons, Inc. 3-Acylamino-1-sulfonylaminocarbonylmethoxy-2-azetidinones
US4534896A (en) * 1983-06-13 1985-08-13 E. R. Squibb & Sons, Inc. 3-Acylamino-2-oxoazetidine-1-(β-oxopropionic acid)
US4587051A (en) * 1983-07-18 1986-05-06 E. R. Squibb & Sons, Inc. Desulfonation process for preparing 2-azetidinones
US4584132A (en) * 1983-08-09 1986-04-22 Hoffmann-La Roche Inc. 1-(N-phosphinylcarbamoyl) β-lactam antibacterial agents
US4559335A (en) * 1983-10-03 1985-12-17 E. R. Squibb & Sons, Inc. 3-Acylamino-1-carboxymethyloxy (or thio) carbonyl-2-azetidinones
US4576749A (en) * 1983-10-03 1986-03-18 E. R. Squibb & Sons, Inc. 3-Acylamino-1-carboxymethylaminocarbonyl-2-azetidinones
US4831130A (en) * 1984-05-31 1989-05-16 Hoffmann-La Roche Inc. β-lactam antibacterial agents
EG18314A (en) * 1985-09-26 1993-02-28 Squibb & Sons Inc Process for preparing of 2-oxo-1((substituted sulfonyl)amino)carbonyl)-azitidines
US4743685A (en) * 1985-09-26 1988-05-10 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]carbonyl]azetidines
AU7541487A (en) * 1986-05-23 1987-12-22 Upjohn Company, The N-1 substituted sulfonylaminocarbonyl, c-4 substituted monobactams
US4801705A (en) * 1986-06-23 1989-01-31 E. R. Squibb & Sons, Inc. 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines
CA1317298C (en) * 1987-03-03 1993-05-04 Upjohn Company (The) Antibiotic sulfonylaminocarbonyl activated .beta.-lactams
US4762922A (en) * 1987-07-01 1988-08-09 Squibb Corporation 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US4772693A (en) * 1987-07-01 1988-09-20 E. R. Squibb & Sons, Inc. 2-oxo-1-((Substituted sulfonyl)amino)-carbonyl)azetidines
US4777252A (en) * 1987-08-13 1988-10-11 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
FI20031113A7 (fi) * 2003-07-29 2005-01-30 Outokumpu Oy Menetelmä ja laitteisto leijupetiuunin arinalta poistettavan materiaalin jäähdyttämiseksi
US7511159B2 (en) * 2003-12-25 2009-03-31 Ono Pharmaceutical Co., Ltd. Azetidine ring compounds and drugs comprising the same
AU2012233003B2 (en) * 2005-12-07 2014-12-18 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
DK1965798T3 (da) 2005-12-07 2011-11-28 Basilea Pharmaceutica Ag Nyttige monobactam-antibiotika
EP2379546A1 (en) 2008-12-19 2011-10-26 Pfizer Inc. Monocarbams
KR20230175175A (ko) * 2020-11-30 2023-12-29 소프로시네 파마슈티칼스 리미티드 알코올 사용 장애(Alcohol Use Disorder)를 치료하기 위한 화합물 및 방법
WO2022261441A2 (en) 2021-06-10 2022-12-15 Sophrosyne Pharmaceuticals Limited Crystalline forms of aldh2 modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2559307C2 (de) * 1975-12-31 1984-05-24 Rheinhold & Mahla Gmbh, 6800 Mannheim Verfahren und Vorrichtung zum Verkleben zweier Materialbahnen
US4195021A (en) * 1977-10-26 1980-03-25 Eli Lilly And Company 1,3-Disubstituted 2-azetidinone antibitotics
DE3069587D1 (en) * 1979-06-08 1984-12-13 Takeda Chemical Industries Ltd 1-sulpho-2-oxoazetidine derivatives, their production and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
ES8307741A1 (es) 1983-07-01
ES521480A0 (es) 1984-06-01
JPH0372616B2 (en, 2012) 1991-11-19
IE820781L (en) 1982-10-09
PT74730A (en) 1982-05-01
ES8405368A1 (es) 1984-06-01
EP0062876B1 (en) 1986-09-24
IL65407A0 (en) 1982-07-30
DE3273405D1 (en) 1986-10-30
EP0062876A1 (en) 1982-10-20
DK162582A (da) 1982-10-10
HU187568B (en) 1986-01-28
PH23122A (en) 1989-05-05
ES8405369A1 (es) 1984-06-01
IE52938B1 (en) 1988-04-13
ZA821768B (en) 1983-01-26
GR76486B (en, 2012) 1984-08-10
ES521479A0 (es) 1984-06-01
CA1246572A (en) 1988-12-13
JPS57179156A (en) 1982-11-04
ATE22439T1 (de) 1986-10-15
NZ199981A (en) 1985-08-16
AU8155782A (en) 1982-10-14
AU561650B2 (en) 1987-05-14
PT74730B (en) 1983-10-25

Similar Documents

Publication Publication Date Title
ES511238A0 (es) "un procedimiento para preparar una beta-lactama".
AU537414B2 (en) Pyroglutamic acid derivatives
ES2001396A6 (es) Procedimiento para la obtencion de derivados de nitrometileno de efecto insecticida.
DE3068233D1 (en) Substituted ureas, their preparation and use as herbicides, and compositions therefor
FR2382434A1 (fr) N'-(4-phenethyloxy substitue)phenyl) - n - methyl - n - methoxyurees et leur utilisation comme herbicides
MY101841A (en) Insecticidal trifluormethyl alkane derivatives.
FI853624A0 (fi) 1-substituerade tetralinderivat, deras framstaellning och anvaendning.
ES462587A1 (es) Procedimiento para preparar esteres pirimidinilicos alcoxi- sustituidos de acidos tionofosfonicos.
ATE46516T1 (de) Phosphonamidthioate-insektizide.
ES8504828A1 (es) Procedimiento para la obtencion de un derivado de organofosfato.
AU579416B2 (en) 3-Amino-2,3-dihydro-1-benzoxepine-compounds and methods for their preparation and pharmaceutical preparations containing these compounds
AU545800B2 (en) New compounds
ES8704912A1 (es) Procedimiento para la obtencion de n-(3-cloro-1,2,4-oxadia- zol-5-il)-ureas
IT1093255B (it) Derivati fenossialcanolaminici
ES2001701A6 (es) Un metodo para preparar compuesto de benzoilurea
IT1111676B (it) Derivati della 2-fenossimetil-morfolina
IT1160302B (it) Derivati della 2-fenossimentil-morfolina
IT1160301B (it) Derivati fenossialcanolaminici
NL7900412A (en) 1-amino-2-hydroxy-3-phenoxy-3-phenyl-propane derivs. - useful as antidepressants
SU782330A1 (ru) Арил-(2-оксиэтиламино)-(4-антипирил)-метаны, проявляющие противовоспалительную активность
ES8605530A1 (es) Procedimiento para la obtencion de triazolil-tionofosfatos

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519